Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

316 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Tumor antigens recognized by T lymphocytes.
Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P, Van Pel A. Boon T, et al. Among authors: cerottini jc. Annu Rev Immunol. 1994;12:337-65. doi: 10.1146/annurev.iy.12.040194.002005. Annu Rev Immunol. 1994. PMID: 8011285 Review.
Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells.
Speiser DE, Pittet MJ, Rimoldi D, Guillaume P, Luescher IF, Liénard D, Lejeune F, Cerottini JC, Romero P. Speiser DE, et al. Among authors: cerottini jc. Semin Cancer Biol. 2003 Dec;13(6):461-72. doi: 10.1016/j.semcancer.2003.09.010. Semin Cancer Biol. 2003. PMID: 15001165 Review.
Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine.
Valmori D, Dutoit V, Ayyoub M, Rimoldi D, Guillaume P, Liénard D, Lejeune F, Cerottini JC, Romero P, Speiser DE. Valmori D, et al. Among authors: cerottini jc. Cancer Immun. 2003 Oct 28;3:15. Cancer Immun. 2003. PMID: 14580186
Efficient induction of tumor antigen-specific CD8+ memory T cells by recombinant lentivectors.
Chapatte L, Colombetti S, Cerottini JC, Lévy F. Chapatte L, et al. Among authors: cerottini jc. Cancer Res. 2006 Jan 15;66(2):1155-60. doi: 10.1158/0008-5472.CAN-05-2597. Cancer Res. 2006. PMID: 16424053
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.
Romero P, Valmori D, Pittet MJ, Zippelius A, Rimoldi D, Lévy F, Dutoit V, Ayyoub M, Rubio-Godoy V, Michielin O, Guillaume P, Batard P, Luescher IF, Lejeune F, Liénard D, Rufer N, Dietrich PY, Speiser DE, Cerottini JC. Romero P, et al. Among authors: cerottini jc. Immunol Rev. 2002 Oct;188:81-96. doi: 10.1034/j.1600-065x.2002.18808.x. Immunol Rev. 2002. PMID: 12445283 Review.
Functional analysis of HLA-A*0201/Melan-A peptide multimer+ CD8+ T cells isolated from an HLA-A*0201- donor: exploring tumor antigen allorestricted recognition.
Dutoit V, Guillaume P, Romero P, Cerottini JC, Valmori D. Dutoit V, et al. Among authors: cerottini jc. Cancer Immun. 2002 Jul 12;2:7. Cancer Immun. 2002. PMID: 12747752
Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.
Bricard G, Cesson V, Devevre E, Bouzourene H, Barbey C, Rufer N, Im JS, Alves PM, Martinet O, Halkic N, Cerottini JC, Romero P, Porcelli SA, Macdonald HR, Speiser DE. Bricard G, et al. Among authors: cerottini jc. J Immunol. 2009 Apr 15;182(8):5140-51. doi: 10.4049/jimmunol.0711086. J Immunol. 2009. PMID: 19342695 Free article.
Immunogenicity of the carcinoembryonic antigen derived peptide 694 in HLA-A2 healthy donors and colorectal carcinoma patients.
Alves PM, Viatte S, Fagerberg T, Michielin O, Bricard G, Bouzourene H, Vuilleumier H, Kruger T, Givel JC, Lévy F, Speiser DE, Cerottini JC, Romero P. Alves PM, et al. Among authors: cerottini jc. Cancer Immunol Immunother. 2007 Nov;56(11):1795-805. doi: 10.1007/s00262-007-0323-2. Epub 2007 Apr 20. Cancer Immunol Immunother. 2007. PMID: 17447064
IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cells.
Barbey C, Baumgaertner P, Devevre E, Rubio-Godoy V, Derre L, Bricard G, Guillaume P, Luescher IF, Liénard D, Cerottini JC, Romero P, Rufer N, Speiser DE. Barbey C, et al. Among authors: cerottini jc. J Immunol. 2007 Mar 15;178(6):3566-74. doi: 10.4049/jimmunol.178.6.3566. J Immunol. 2007. PMID: 17339453 Free article.
The human T cell response to melanoma antigens.
Romero P, Cerottini JC, Speiser DE. Romero P, et al. Among authors: cerottini jc. Adv Immunol. 2006;92:187-224. doi: 10.1016/S0065-2776(06)92005-7. Adv Immunol. 2006. PMID: 17145305 Review.
316 results
Jump to page
Feedback